Circulating semicarbazide-sensitive amine oxidase is raised both in Type I (insulin-dependent), in Type II (non-insulin-dependent) diabetes mellitus and even in childhood Type I diabetes at first clinical diagnosis

Diabetologia

Volumn 42, Issue 2, 1999, Pages 233-237

  Boomsma, F ^b   Van Den Meiracker, A H ^c   Winkel, S ^c   Aanstoot, H J ^a   Batstra, M R ^a   Man In 't Veld, A J ^c   Bruining, G J ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c NONE

Author keywords

Methylamine; Semicarbazide sensitive amine oxidase; Type I diabetes; Type II diabetes

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); SEMICARBAZIDE;

ADOLESCENT; ADULT; ARTICLE; BLOOD VESSEL INJURY; CELL DAMAGE; CHILD; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMALE; GLYCOSYLATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGRESSION ANALYSIS; SMOOTH MUSCLE FIBER;

ADOLESCENT; ADULT; AGED; AMINE OXIDASE (COPPER-CONTAINING); CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GLUTAMATE DECARBOXYLASE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFANT; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SEMICARBAZIDES;

EID: 0000687067     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051143     Document Type: Article

References (31)

1. 1. Yu PH, Zuo D-M (1993) Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Diabetes 42: 594-603
2. 2. McEwen C, Cohen JD (1963) An amine oxidase in normal human serum. J Lab Clin Med 62: 766
3. 3. Lewinsohn R (1981) Amine oxidase in human blood vessels and non-vascular smooth muscle. J Pharm Pharmacol 33: 569-575
4. 4. Norqvist A, Oreland L, Fowler CJ (1982) Some properties of monoamine oxidase and a semicarbazide sensitive amine oxidase capable of the deamination of 5-hydroxytryptamine from porcine dental pulp. Biochem Pharmacol 31: 2739-2744
5. 5. Barrand MA, Callingham BA (1982) Monoamine oxidase activities in brown adipose tissue of the rat: some properties and subcellular distribution. Biochem Pharmacol 31: 2177-2184
6. 6. Falk MC, Staton AJ, Williams TJ (1983) Heterogeneity of pig plasma amine oxidase: molecular and catalytic properties of chromatographically isolated forms. Biochem 22: 3746-3751
7. 7. Precious E, Gunn CE, Lyles GA (1988) Deamination of methylamine by semicarbazide-sensitive amine oxidase in human umbilical artery and rat aorta. Biochem Pharmacol 37: 707-713
8. 8. Elliott J, Callingham BA, Sharman DF (1989) Semicarbazide-sensitive amine oxidase (SSAO) of the rat aorta. Biochem Pharmacol 38: 1507-1515
9. 9. Boor PJ, Hysmith RM, Sanduja R (1990) A role for a new vascular enzyme in the metabolism of xenobiotic amines. Circ Res 66: 249-252
10. 10. Lyles GA, Holt A, Marshall CMS (1990) Further studies on the metabolism of methylamine by semicarbazide-sensitive amine oxidase activities in human plasma, umbilical artery and rat aorta. J Pharm Pharmacol 42: 322-338
11. 11. Elliott WH (1960) Methylglyoxal formation from amino-acetone by ox plasma. Nature 184: 467-468
12. 12. Ray S, Ray M (1983) Formation of methylglyoxal from aminoacetone by amine oxidase from goat plasma. J Biol Chem 258: 3461-3462
13. 13. Lyles GA, Chalmers J (1992) The metabolism of aminoacetone to methylglyoxal by semicarbazide-sensitive amine oxidase in human umbilical artery. Biochem Pharmacol 43: 1409-1414
14. 14. Boomsma F, Derkx FHM, van den Meiracker AH, Man in 't Veld AJ, Schalekamp MADH (1995) Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated hemoglobin. Clin Sci 88: 675-679
15. 15. Gomis R, Sener A, Malaisse-Lagae F, Malaisse WJ (1983) Transglutaminase activity in pancreatic islets. Biochim Biophys Acta 760: 384-388
16. 16. Lebrun P, Atwater I, Rosario LM, Herchuelz A, Malaisse WJ (1985) Dissociation by methylamine of insulin release from glucose-induced electrical activity in isolated mouse islets of Langerhans. Metabolism 34: 1122-1127
17. 17. Hayes BE, Clarke DE (1990) Semicarbazide-sensitive amine oxidase activity in streptozotocin diabetic rats. Res Commun Chem Pathol Pharmacol 69: 71-83
18. 18. Tryding N, Nilsson SE, Tufvesson G et al. (1969) Physiological and pathological influences on serum monoamine oxidase level. Scand J Clin Lab Invest 23: 79-84
19. 19. Murphy DL, Wright C, Buchsbaum M, Nichols A, Costa JL, Wyatt RJ (1976) Platelet and plasma amine oxidase activity in 680 normals: sex and age differences and stability over time. Biochem Med 16: 254-265
20. 20. Dijk J van, Boomsma F, Alberts G, Man in 't Veld AJ, Schalekamp MADH (1995) Determination of semicarbazide-sensitive amine oxidase in human plasma by high-performance liquid chromatography with fluorimetric detection. J Chromatogr B Biomed Appl 663: 43-50
21. 21. Batstra M, Pina M, Quan J, Mulder P et al. (1997) Fluctuations in GAD65 antibodies after clinical diagnosis of IDDM in young children. Diabetes Care 20: 642-644
22. 22. Petersen JS, Hejnaes KR, Moody A, Karlsen AE, Marshall MO, Hoier-Madsen M (1994) Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 43: 459-467
23. 23. Boomsma F, van Veldhuisen DJ, de Kam PJ et al. (1997) Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure. Cardiovasc Res 33: 387-391
24. 24. Enrique-Taracon G, Marti L, Morin N et al. (1998) Role of semicarbazide-sensitive amine oxidase on glucose transport and GLUT4 recruitment to the cell surface in adipose cells. J Biol Chem 273: 8025-8032
25. 25. Callingham BA, Crosbie AE, Rous BA (1995) Some aspects of the pathophysiology of semicarbazide-sensitive amine oxidase enzymes. In: Yu PM, Tipton KF, Boulton AA (eds) Progress in brain research, vol. 106. Elsevier, Amsterdam, pp 305-321
26. 26. McLellan AC, Thornalley PJ, Benn J, Sonksen PH (1994) Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin Sci 87: 21-29
27. 27. Lo TWC, Selwood T, Thornalley PJ (1994) The reaction of methylglyoxal with aminoguanidine under physiological conditions and prevention of methylglyoxal binding to plasma proteins. Biochem Pharmacol 48: 1865-1870
28. 28. Yu PH, Zuo DM (1997) Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications. Diabetologia 40: 1243-1250
29. 29. Thornalley PJ (1990)The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life. Biochem J 269: 1-11
30. 30. Jansson L (1994) The regulation of pancreatic islet blood flow. Diabetes Metab Rev 10: 407-4-16
31. 2 radicals in 'autoimmune' diabetes. Immunol Cell Biol 67: 85-87